Servier Deutschland Gmbh

Servier Deutschland Gmbh company information, Employees & Contact Information

Servier ist ein global agierendes, forschendes Pharmaunternehmen, das als private Stiftung geführt wird. Gegründet, um uns der Gesundheit und dem Wohl von Patient:innen zu verpflichten, leisten unsere mehr als 22.000 Kolleg:innen weltweit einen bedeutenden sozialen und gesellschaftlichen Beitrag sowohl für Patient:innen als auch für eine nachhaltige Umwelt. Servier hat seinen Hauptsitz in Frankreich, ist in rund 140 Ländern vertreten und erzielte im Geschäftsjahr 2023/2024 Umsatzerlöse in Höhe von 5,9 Milliarden Euro. Die deutsche Niederlassung Servier Deutschland GmbH wurde 1996 in München gegründet. Dort fokussieren wir uns auf den Vertrieb von innovativen Therapien in den Bereichen Hämatologie und Onkologie. Weitere Informationen https://www.servier.de/ueber-uns/unternehmen http://www.servier.de/impressum/ https://www.servier.de/datenschutz-uebersichtsseite https://www.servier.de/nebenwirkungsmeldung

Company Details

Employees
107
Founded
-
Address
Elsenheimerstr. 53, München,bayern 80687,germany
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
München, Bayern
Looking for a particular Servier Deutschland Gmbh employee's phone or email?

Servier Deutschland Gmbh Questions

News

Ropes & Gray Advises Black Diamond Therapeutics in Global Licensing Deal with Servier - Ropes & Gray LLP

Ropes & Gray Advises Black Diamond Therapeutics in Global Licensing Deal with Servier Ropes & Gray LLP

JPM25: As Servier cements oncology bona fides, US chief stresses importance of 'staying authentic' - Fierce Pharma

JPM25: As Servier cements oncology bona fides, US chief stresses importance of 'staying authentic' Fierce Pharma

The Research and Development Institute in Paris-Saclay - Servier

The Research and Development Institute in Paris-Saclay Servier

Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma - PR Newswire

Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma PR Newswire

Dentons advises Servier on the sale of Biogaran - Dentons

Dentons advises Servier on the sale of Biogaran Dentons

Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA - BioSpace

Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA BioSpace

Schema describing Servier’s governance structure - Servier

Schema describing Servier’s governance structure Servier

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M - Fierce Pharma

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M Fierce Pharma

Learn more about our development portfolio - Servier

Learn more about our development portfolio Servier

See our bases throughout the world - Servier

See our bases throughout the world Servier

Virginie Dominguez receives Trophée des Femmes de l’industrie for digital sector! - Servier

Virginie Dominguez receives Trophée des Femmes de l’industrie for digital sector! Servier

Servier tackles environmental challenges, transforming itself for a more sustainable future! - Servier

Servier tackles environmental challenges, transforming itself for a more sustainable future! Servier

The strategic importance of supply chain continuity - Servier

The strategic importance of supply chain continuity Servier

Servier x Owkin: AI-driven precision therapeutics - Servier

Servier x Owkin: AI-driven precision therapeutics Servier

Servier reveals a new visual identity - Servier

Servier reveals a new visual identity Servier

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting! - Servier

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting! Servier

PRISM BioLab, a new partner for Servier in immuno-oncology - Servier

PRISM BioLab, a new partner for Servier in immuno-oncology Servier

Paris-Saclay: our R&D Institute opens its doors! - Servier

Paris-Saclay: our R&D Institute opens its doors! Servier

Paris-Saclay: Our incubator is opening its doors! - Servier

Paris-Saclay: Our incubator is opening its doors! Servier

Oril Industrie, Servier’s centre of excellence in chemistry for the past 60 years! - Servier

Oril Industrie, Servier’s centre of excellence in chemistry for the past 60 years! Servier

Fostering a healthy environment - Servier

Fostering a healthy environment Servier

French Pharma Giant Launches Research Institute - Site Selection Magazine

French Pharma Giant Launches Research Institute Site Selection Magazine

Servier Nabs Solid Tumor Asset in up to $780M Deal With Black Diamond - BioSpace

Servier Nabs Solid Tumor Asset in up to $780M Deal With Black Diamond BioSpace

A Servier campaign to raise awareness about angina pectoris - Servier

A Servier campaign to raise awareness about angina pectoris Servier

Servier found guilty of fraud, manslaughter in long-running case over deadly weight-loss pill - Fierce Pharma

Servier found guilty of fraud, manslaughter in long-running case over deadly weight-loss pill Fierce Pharma

$530 Million Deal: IDEAYA's Breakthrough Eye Cancer Drug Darovasertib Gets Global Partnership with Servier - Stock Titan

$530 Million Deal: IDEAYA's Breakthrough Eye Cancer Drug Darovasertib Gets Global Partnership with Servier Stock Titan

Servier found guilty of deception and manslaughter over deadly weight loss pill - Pharmaceutical Technology

Servier found guilty of deception and manslaughter over deadly weight loss pill Pharmaceutical Technology

World Hypertension Day: Servier shows its commitment! - Servier

World Hypertension Day: Servier shows its commitment! Servier

Servier: Bringing innovation to patients - European Pharmaceutical Review

Servier: Bringing innovation to patients European Pharmaceutical Review

A delegation from Institut De Recherches Servier visited School of Pharmaceutical Sciences of SYSU - 中山大学SUN YAT-SEN UNIVERSITY

A delegation from Institut De Recherches Servier visited School of Pharmaceutical Sciences of SYSU 中山大学SUN YAT-SEN UNIVERSITY

Deep generative models for ligand-based de novo design applied to multi-parametric optimization - Wiley Online Library

Deep generative models for ligand-based de novo design applied to multi-parametric optimization Wiley Online Library

Servier, VCs invest $21 mln to create new Québec biotech startup - Venture Capital Journal

Servier, VCs invest $21 mln to create new Québec biotech startup Venture Capital Journal

The ECJ’s ruling in Servier: Never Settle For Less - Stibbe

The ECJ’s ruling in Servier: Never Settle For Less Stibbe

Servier lays off reps in Argentina - pharmabiz.net

Servier lays off reps in Argentina pharmabiz.net

Foundation stone laid for future Servier Paris-Saclay Research Institute - Vinci

Foundation stone laid for future Servier Paris-Saclay Research Institute Vinci

Intestines and colon - Servier Medical Art

Intestines and colon Servier Medical Art

French drugmaker Servier ordered to pay $471m over Mediator scandal - RFI

French drugmaker Servier ordered to pay $471m over Mediator scandal RFI

Servier announces job cuts as pressures mount - PMLiVE

Servier announces job cuts as pressures mount PMLiVE

French pharma giant Servier found guilty in Mediator slimming drug scandal - RFI

French pharma giant Servier found guilty in Mediator slimming drug scandal RFI

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant